{ "@context": "https://schema.org", "@graph": [ { "@type": "LegalCase", "@id": "case-7989", "postId": 7989, "name": "Pomdoctor Limited", "description": "If you purchased or acquired securities in Pomdoctor between October 9, 2025 and December 11, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Pomdoctor Limited (\u201cPomdoctor\u201d or the \u201cCompany\u201d) (NASDAQ: POM) and reminds investors of the April 6, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) that PomDoctor was the subject of a fraudulent stock promotion scheme involving social media based misinformation and impersonated financial professionals; (2) that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; (3) that PomDoctor\u2019s public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price; and (4) that, as a result of the foregoing, Defendants\u2019 positive statements about the Company\u2019s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Lead Plaintiff Deadline: April 6, 2026 \u00a0Call\u00a0Partner Josh Wilson\u00a0at\u00a0877-247-4292\u00a0or\u00a0212-983-9330 (Ext. 1310) Or\u00a0submit your information below\u00a0to learn about your rights.", "identifier": "POM", "legal": { "court": "United States District Court for the Southern District of New York", "jurisdiction": "Federal (United States), federal securities laws" }, "classPeriod": { "start": "10/09/2025", "end": "12/11/2025" }, "leadPlaintiffDeadline": "04/06/2026", "caseStatus": { "name": "", "slug": "" }, "practiceArea": { "name": "Securities Litigation", "slug": "securities-litigation" }, "url": "https://faruqilaw.com/case/pomdoctor-limited/", "canonicalUrl": "https://faruqilaw.com/case/pomdoctor-limited/", "datePublished": "2026-02-05T22:22:32+00:00", "dateModified": "2026-02-05T22:23:43+00:00", "associatedOrganization": { "@id": "case-7989-org" }, "legalService": { "@id": "case-7989-legalservice" }, "hasPart": [ { "@id": "case-7989-faq" }, { "@id": "case-7989-press-list" } ], "legalRepresentation": [ { "@id": "case-7989-attorney-516" }, { "@id": "case-7989-attorney-506" } ] }, { "@type": "Organization", "@id": "case-7989-org", "name": "Pomdoctor Limited", "identifier": "POM", "logo": "https://faruqilaw.com/wp-content/uploads/2025/05/logo.svg", "url": "https://ir.7shiliu.com/" }, { "@type": "LegalService", "@id": "case-7989-legalservice", "name": "Faruqi & Faruqi, LLP", "url": "https://faruqilaw.com/", "telephone": "+1-212-983-9330", "logo": "https://faruqilaw.com/wp-content/uploads/2025/05/logo.svg", "address": { "@type": "PostalAddress", "streetAddress": "685 3rd Ave 26th Floor", "addressLocality": "New York", "postalCode": "10017", "addressRegion": "NY", "addressCountry": "US" }, "sameAs": [ "https://faruqilaw.com/", "https://maps.google.com/?cid=3247549158190754383" ] }, { "@type": "Person", "@id": "case-7989-attorney-516", "name": "James M. Wilson, Jr.", "worksFor": { "@id": "case-7989-legalservice" } }, { "@type": "Person", "@id": "case-7989-attorney-506", "name": "Robert W. Killorin", "worksFor": { "@id": "case-7989-legalservice" } }, { "@type": "FAQPage", "@id": "case-7989-faq", "mainEntity": [ { "@type": "Question", "name": "What is the Pomdoctor securities class action lawsuit about?", "acceptedAnswer": { "@type": "Answer", "text": "The lawsuit alleges Pomdoctor misled investors by failing to disclose an alleged stock promotion scheme involving social media misinformation, artificial trading activity, and insider or affiliate share dumping that inflated the stock price." } }, { "@type": "Question", "name": "How does a stock promotion scheme affect Pomdoctor investors?", "acceptedAnswer": { "@type": "Answer", "text": "Investors allege false promotional activity artificially boosted Pomdoctor\u2019s share price, allowing insiders or affiliates to sell at inflated levels before the stock declined, causing losses to public shareholders." } }, { "@type": "Question", "name": "What disclosures are Pomdoctor executives accused of omitting?", "acceptedAnswer": { "@type": "Answer", "text": "The complaint claims Pomdoctor failed to disclose false rumors, coordinated promotional activity, and artificial trading that were driving its stock price, making public statements about the company misleading." } }, { "@type": "Question", "name": "Who may qualify to participate in the Pomdoctor class action?", "acceptedAnswer": { "@type": "Answer", "text": "Investors who purchased Pomdoctor stock during the period of alleged artificial price inflation and suffered losses after corrective disclosures or price declines may be eligible to participate in the class action." } }, { "@type": "Question", "name": "What is the deadline to seek lead plaintiff status in the Pomdoctor lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "Investors seeking to be appointed lead plaintiff in the federal securities class action against Pomdoctor must file a motion by April 6, 2026, to preserve their right to represent the class." } } ] }, { "@type": "NewsArticle", "@id": "case-7989-press-1", "headline": "POM Stock Surge Amid Market Expansion and Strategic Moves", "url": "https://www.timothysykes.com/news/pomdoctor-limited-pom-news-2025_12_05/", "datePublished": "2025-12-05" }, { "@type": "NewsArticle", "@id": "case-7989-press-2", "headline": "Pomdoctor (POM) Losses Persist as Price-to-Sales Premium Tests Bullish Scaling Narrative", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-pom/pomdoctor/news/pomdoctor-pom-losses-persist-as-price-to-sales-premium-tests", "datePublished": "2025-12-04" }, { "@type": "ItemList", "@id": "case-7989-press-list", "itemListElement": [ { "@type": "ListItem", "position": 1, "item": { "@id": "case-7989-press-1" } }, { "@type": "ListItem", "position": 2, "item": { "@id": "case-7989-press-2" } } ] } ] }

Pomdoctor Limited

Pomdoctor Limited

Join Action
Case Details
Ticker POM
Class Period 10/09/2025 - 12/11/2025
Lead Plaintiff Deadline 04/06/2026
Days Left to Seek Plaintiff
59

If you are a Pomdoctor investor who suffered a loss and would like to learn more, you can provide your information below:

If you purchased or acquired securities in Pomdoctor between October 9, 2025 and December 11, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Pomdoctor Limited (“Pomdoctor” or the “Company”) (NASDAQ: POM) and reminds investors of the April 6, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) that PomDoctor was the subject of a fraudulent stock promotion scheme involving social media based misinformation and impersonated financial professionals; (2) that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; (3) that PomDoctor’s public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

📞 Lead Plaintiff Deadline: April 6, 2026

💻 Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310)
Or submit your information below to learn about your rights.

Join Action
Pomdoctor Limited
1
1
1
1

Accepted file types: xls, xlsx, doc, docx, pdf, jpg, jpeg, png, Max. file size: 50 MB, Max. files: 5.
You may redact account numbers from your uploaded documents.

File name:

File size:

Counsel
James M. Wilson, Jr.
jwilson@faruqilaw.com
Phone (212) 983-9330
Fax (212) 983-9331
Robert W. Killorin
rkillorin@faruqilaw.com
Phone (404) 847-0617
Fax (404) 506-9534
Office
New York
685 Third Avenue 26th Floor New York New York 10017
Phone (212) 983-9330
Fax (212) 983-9331

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.
Send Us a Message
New York
685 Third Avenue 26th Floor
New York New York 10017
(877) 247-4292 / (212) 983-9330
(212) 983-9331
Los Angeles
1901 Avenue of the Stars Suite 1060
Los Angeles California 90067
(424) 256-2884
(424) 256-2885
Atlanta
3565 Piedmont Road NE Building Four, Suite 380
Atlanta Georgia 30305
(404) 847-0617
(404) 506-9534
Philadelphia
1617 JFK Boulevard, Suite 1550 Philadelphia
Pennsylvania 19103
(215) 277-5770
(215) 277-5771